FalconX

Companies

FalconX is a San Francisco-based institutional cryptocurrency trading platform founded in 2018, offering prime brokerage, OTC trading, and derivatives services to hedge funds, family offices, and asset managers. The company provides deep Bitcoin liquidity through algorithmic trading and has raised over $150 million in venture capital. FalconX is notable for offering credit lines to institutional clients, enabling them to trade Bitcoin without pre-funding their accounts, a feature particularly valued by sophisticated institutional traders.

Details

Ceo: Raghu Yarlagadda
Public: No
Sector: trading_desk
Known For: Institutional Bitcoin prime brokerage and OTC trading; credit lines for institutional crypto trading
Company Type: Institutional Prime Brokerage
Founded Year: 2018
Headquarters: San Mateo, California, USA
Bitcoin Strategy: Institutional crypto prime brokerage providing spot, derivatives, OTC, and financing services to hedge funds, family offices, and institutions seeking Bitcoin exposure.
Bitcoin Holdings Note: Private company — holds operational BTC as prime broker. No public treasury disclosure.

Links

twitter

More Companies

Strategy (formerly MicroStrategy)

Strategy (Nasdaq: MSTR), formerly MicroStrategy, is the world's largest corporate Bitcoin holder. Founded by Michael Saylor, the company rebranded in 2025 to reflect its identity as a Bitcoin treasury company. It holds over 500,000 BTC accumulated through equity and debt financing, pioneering the corporate Bitcoin standard that inspired hundreds of companies worldwide.

ACINQ

ACINQ is a French Bitcoin infrastructure company and the developer of Eclair, one of the three major Lightning Network implementations. Founded in 2014, ACINQ builds Phoenix Wallet (a non-custodial Lightning wallet) and operates the ACINQ Lightning node, one of the most well-connected nodes on the Lightning Network.

Acurx Pharmaceuticals

Acurx Pharmaceuticals (NASDAQ: ACXP) is a US biopharmaceutical company that made headlines in November 2021 by adopting Bitcoin as its primary treasury reserve asset — one of the first pharmaceutical companies to do so. The company approved purchasing $1 million in Bitcoin and has continued to hold BTC alongside its drug development pipeline focused on antibiotics. Notable for crossing industry boundaries to embrace the Bitcoin standard.